PRMT5 and glioblastoma: Mechanistically, suppression of protein arginine methyltransferase 5 (PRMT5) attenuates the expression of RNF168 in methylthioadenosine phosphorylase (MTAP)-deficient glioblastoma cells, contributing to the destabilization of H2AX by SMURF2.